Venmax Drugs & Pharmaceuticals Technical Analysis

Venmax Drugs & Pharmaceuticals Ltd Technical Analysis

Venmax Drugs & Pharmaceuticals Ltd technical analysis is gaining attention among traders and investors tracking Venmax Drugs & Pharmaceuticals Ltd Technical Analysis trends in the Indian stock market. Venmax Drugs & Pharmaceuticals Ltd (NSE: , BSE: 531015) is currently trading at ₹23.96, showing a -0.17% move as of Mon, May 25, 2026.

This detailed Venmax Drugs & Pharmaceuticals Ltd technical analysis covers support & resistance levels, moving averages, indicators, and overall market sentiment to help investors make informed decisions.

Venmax Drugs & Pharmaceuticals Ltd Stock Overview

Venmax Drugs & Pharmaceuticals Ltd operates in the Health technology sector under the Pharmaceuticals: major industry. With a market capitalization of ₹0 and a PE ratio of 0, Venmax Drugs & Pharmaceuticals Ltd remains a key stock to watch in Venmax Drugs & Pharmaceuticals Ltd Technical Analysis searches.

Key Metrics

• Market Cap: ₹0
• PE Ratio: 0
• Dividend Yield: 0
• Sector: Health technology
• Industry: Pharmaceuticals: major

These fundamentals play an important role in Venmax Drugs & Pharmaceuticals Ltd technical analysis and valuation tracking.

Venmax Drugs & Pharmaceuticals Ltd Support and Resistance Levels

Classic Pivot Levels

In Venmax Drugs & Pharmaceuticals Ltd technical analysis, pivot levels help identify potential reversal and breakout zones.

• Resistance 3: 41.71
• Resistance 2: 33.72
• Resistance 1: 29.44
• Pivot Point: 25.73
• Support 1: 21.45
• Support 2: 17.74
• Support 3: 9.75

Conditional Insight

Venmax Drugs & Pharmaceuticals Ltd technical analysis suggests a bearish to neutral trend as the price is below the pivot point. Immediate support is seen near 21.45 and 17.74.

Fibonacci Levels Analysis

Fibonacci levels are widely used in Venmax Drugs & Pharmaceuticals Ltd technical analysis to identify retracement zones.

• Fibonacci R3: 33.72
• Fibonacci R2: 30.66
• Fibonacci R1: 28.78
• Fibonacci Pivot: 25.73
• Fibonacci S1: 22.67
• Fibonacci S2: 20.79
• Fibonacci S3: 17.74

Venmax Drugs & Pharmaceuticals Ltd technical analysis indicates consolidation between Fibonacci pivot and resistance zones.

Venmax Drugs & Pharmaceuticals Ltd Moving Average Analysis

Moving averages are key indicators in Venmax Drugs & Pharmaceuticals Ltd technical analysis for identifying trend direction.

• 10 EMA: 24.29
• 20 EMA: 24.63
• 30 EMA: 24.85
• 50 EMA: 25.12
• 100 EMA: 25.52
• 200 EMA: 25.20

Trend Logic

Venmax Drugs & Pharmaceuticals Ltd technical analysis indicates bearish pressure, with price trading below key moving averages.

Long-term trend in Venmax Drugs & Pharmaceuticals Ltd technical analysis remains positive above 200 EMA.

Venmax Drugs & Pharmaceuticals Ltd Technical Indicators Overview

Momentum Indicators

• RSI: 42.36
• MACD: -0.41
• Signal: -0.33
• ADX: 10.07
• Momentum: -0.10

RSI Logic

Venmax Drugs & Pharmaceuticals Ltd technical analysis shows RSI in neutral range, suggesting consolidation.

MACD Logic

Venmax Drugs & Pharmaceuticals Ltd technical analysis indicates bearish momentum with MACD below signal line.

Venmax Drugs & Pharmaceuticals Ltd Overall Recommendation

• Overall Recommendation Score: -0.45
• Moving Average Recommendation: -0.80
• Other Indicators Recommendation: -0.09

Overall Venmax Drugs & Pharmaceuticals Ltd technical analysis sentiment remains neutral with mixed signals.

Venmax Drugs & Pharmaceuticals Ltd Technical Analysis Conclusion

Venmax Drugs & Pharmaceuticals Ltd technical analysis suggests that traders should closely monitor price action around ₹23.96 and key pivot level 25.73. Breakouts above resistance or breakdown below support will define the next trend in Venmax Drugs & Pharmaceuticals Ltd technical analysis.

Investors searching for Venmax Drugs & Pharmaceuticals Ltd Technical Analysis should track moving averages, RSI levels, and volume trends to identify potential entry and exit opportunities. As market conditions change, Venmax Drugs & Pharmaceuticals Ltd technical analysis will continue to play a crucial role in short-term trading and long-term investment strategies.